ARS Pharmaceuticals (SPRY) Treasury Shares (2020 - 2023)

ARS Pharmaceuticals (SPRY) has 4 years of Treasury Shares data on file, last reported at $30.8 million in Q2 2023.

• For the quarter ending Q2 2023, Treasury Shares rose 299.82% year-over-year to $30.8 million; the trailing twelve-month figure through Jun 2023 stood at $30.8 million (up 299.82% YoY), and the FY2021 full-year result was $606060.0, down 87.28% from the prior year.
• Treasury Shares grew to $30.8 million in Q2 2023, from $9.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $77.1 million in Q3 2020 to a low of $606060.0 in Q4 2021.
• A 4-year average of $21.8 million and a median of $9.3 million in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares tumbled 87.28% in 2021 and jumped 299.82% in 2023, its largest moves.
• Tracing SPRY's Treasury Shares over 4 years: stood at $4.8 million in 2020, then plunged by 87.28% to $606060.0 in 2021, then surged by 1440.62% to $9.3 million in 2022, then soared by 229.39% to $30.8 million in 2023.
• Business Quant data shows SPRY's Treasury Shares at $30.8 million in Q2 2023, $9.3 million in Q3 2022, and $7.7 million in Q2 2022.